Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Clinical Presentation and Diagnosis of Distal Symmetric Polyneuropathy (DSP)

Sensory Manifestations

  • Symptoms of DSP typically begin symmetrically in the toes and feet, later progressing to fingertips as the condition advances in a length-dependent pattern 1
  • Patients experience distal paresthesia, hyperesthesia, numbness, and sensory loss that affects the feet more than the hands 2
  • Sensory symptoms commonly include pain and positive sensory symptoms in a stocking-and-glove distribution, changes in proprioception and vibratory sensitivity, and elevated touch detection threshold and impaired sharpness detection 2

Motor Involvement

  • Motor impairment is relatively rare compared to sensory deficits in DSP, with motor symptoms typically consisting of mild to severe distal weakness in the lower limbs, occurring in approximately 10% of patients 2
  • Motor nerve involvement is often a later manifestation after sensory symptoms have become established 3

Evidence from Specific Neuropathy Types

  • Small fiber polyneuropathy, a common subtype of DSP, presents with prominent pain and autonomic symptoms with minimal or absent motor findings 1
  • Skin biopsy with intraepidermal nerve fiber (IENF) density assessment is a validated marker of small fiber sensory pathology, highlighting the predominance of sensory involvement 4
  • IENF are the nerve terminals of somatic unmyelinated C fibers, which are predominantly affected in small fiber sensory neuropathy (SFSN) 5

Diagnostic Considerations

  • Physical examination in DSP typically reveals distal sensory loss, reduced or absent reflexes, and sometimes distal muscle weakness 1
  • Autonomic symptoms may also be present in DSP, including orthostatic hypotension, alternating diarrhea and constipation, urinary retention, and sexual dysfunction 1
  • Orthostatic hypotension has been reported in about 10% of patients with certain types of medication-induced DSP 2
  • Autonomic testing can document autonomic system dysfunction in polyneuropathy, which is particularly relevant to small fiber polyneuropathy 4